The Direxion Daily S&P Biotech Bull 3x Shares (LABU) experienced a significant week-over-week outflow of approximately $88.4 million, marking a 10.9% decrease in outstanding shares from 4,574,486 to 4,074,486. This decline reflects notable investor movement in biotech-related ETFs.
As of the latest trade, LABU is priced at $166.64, with a 52-week range between $32.55 and $186.245. The performance data is crucial as LABU holds key biotech stocks, including Revolution Medicines Inc (RVMD) at +0.1%, Moderna Inc (MRNA) at -2.3%, and Krystal Biotech Inc (KRYS) at -2.4%.
